Today IsoPicTM, iCellate's CTC isolation device received CE-approval according to the IVD-directive. IsoPic is the fourth generation of iCellate's CTC isolation devices, but the first one that is CE-marked and commercially available.
The prototypes prior to the development of IsoPicTM has build the knowledge base in order to now have a fully automated, high yield and easy to use medical device.
IsoPicTM will be available only in iCellate's lab as a part of the companies service offering. Please contact Iohn Ryott, VP Sales & Marketing, or Christer Ericsson, CSO, if you have questions regarding iCellate's services.